About Innovative Clinical Strategies

Your partner in clinical strategy, execution, and market entry

We help medtech startups design and run efficient, science-driven clinical programs that accelerate regulatory approval and commercialization.

Our services

Trusted by Medtech Startups

Our Mission

To empower medtech startups by developing and executing scientifically rigorous clinical strategies that support timely regulatory approvals and bring innovative therapies to patients worldwide.

Our Vision

To be recognized as a trusted leader and partner in clinical research - delivering high-impact, ethically sound, and scientifically credible evidence for the innovative medical technologies.

Why work with us?

20+ years of experience

In leading global clinical trials & operations across North America, Europe, Japan and Australia.

20+ years of experience

In leading global clinical trials & operations across North America, Europe, Japan and Australia.

20+ years of experience

In leading global clinical trials & operations across North America, Europe, Japan and Australia.

50+ global trials

4,000+ patients with obesity, GERD, chronic sinusitis, rheumatoid arthritis and emphysema.

50+ global trials

4,000+ patients with obesity, GERD, chronic sinusitis, rheumatoid arthritis and emphysema.

50+ global trials

4,000+ patients with obesity, GERD, chronic sinusitis, rheumatoid arthritis and emphysema.

Expertise in leveraging AI

For patient recruitment & trial efficiency.

Expertise in leveraging AI

For patient recruitment & trial efficiency.

Expertise in leveraging AI

For patient recruitment & trial efficiency.

Multilingual & global reach

Fluent in English, French, Polish and advanced in Spanish.

Multilingual & global reach

Fluent in English, French, Polish and advanced in Spanish.

Multilingual & global reach

Fluent in English, French, Polish and advanced in Spanish.

Get in touch

Anna K Gawlicka, PhD, MBA

President & Chief Clinical Officer, Innovative Clinical Strategies, LLC

Anna K Gawlicka, PhD, MBA

President & Chief Clinical Officer, Innovative Clinical Strategies, LLC

Anna is a clinical research executive with 20+ years global leadership.With a PhD in Nutrition and an MBA in Healthcare, Anna has successfully led 50+ clinical trials across diverse therapeutic area by seamlessly integrating science, strategy, and execution.

Selected peer-reviewed publications

Hoffman V, Mulder K, Topuria I, Gawlicka AK, Kallman JE. Reduction in healthcare resource use through 24 months following sinus surgery with steroid-eluting implants in chronic rhinosinusitis patients with and without nasal polyps: a real-world study. Curr Med Res Opin. 2023 Dec;39(12):1613-1619. Link to PubMed

Stolovitzky JP, Kern RC, Han JK, Forwith KD, Ow RA, Wright SK, Gould A, Matheny KE, Karanfilov B, Huang S, Stambaugh JW, Gawlicka AK. In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled Analysis. Am J Rhinol Allergy. 2019 Sep;33(5):545-558. Link to PubMed

Kern RC, Stolovitzky JP, Silvers SL, Singh A, Lee JT, Yen DM, Iloreta AMC Jr, Langford FPJ, Karanfilov B, Matheny KE, Stambaugh JW, Gawlicka AK, RESOLVE II study investigators. A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps. Int Forum Allergy Rhinol. 2018 Apr;8(4):471-481. Link to PubMed